$JBI Balance Sheet | Understand Stock

$JBI

$4.30 +$0.02 (0.47%) Close

$JBI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jul 4, 2026	Q1 FY2026 As of Apr 4, 2026	Q4 FY2025 As of Jan 3, 2026	Q3 FY2025 As of Sep 27, 2025	Q2 FY2025 As of Jun 28, 2025	Q1 FY2025 As of Mar 29, 2025	Q4 FY2024 As of Dec 28, 2024	Q3 FY2024 As of Sep 28, 2024	Q2 FY2024 As of Jun 29, 2024	Q1 FY2024 As of Mar 30, 2024	Q4 FY2023 As of Dec 30, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jul 1, 2023	Q1 FY2023 As of Apr 1, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Oct 1, 2022	Q2 FY2022 As of Jul 2, 2022	Q1 FY2022 As of Apr 2, 2022	Q4 FY2021 As of Jan 1, 2022	Q3 FY2021 As of Sep 25, 2021
ASSETS
Current Assets
Cash and cash equivalents
Accounts receivable, less allowance for credit losses of $12.5 and $12.1 as of July 4, 2026 and January 3, 2026, respectively
Costs and estimated earnings in excess of billing on uncompleted contracts
Contract assets
Inventories
Prepaid expenses
Other current assets
Total current assets

Property, plant, and equipment, net
Customer relationships, net
Customer relationships, net
Trademarks and Trade Names
Other intangibles
Total customer relationships, net

Tradename and trademarks
Trademarks and Trade Names
Total tradename and trademarks

Other intangibles, net
Right-of-use assets, net
Intangible assets, net
Goodwill
Deferred tax assets, net
Other assets
Total assets

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable
Billing in excess of costs and estimated earnings on uncompleted contracts
Contract liabilities
Current maturities of long-term debt
Other accrued expenses
Other accrued liabilities
Accrued expenses and other current liabilities
Total current liabilities

Debt outstanding
Long-term debt, net
Deferred tax liabilities, net
Derivative warrant liability
Other long-term liabilities
Total liabilities
STOCKHOLDERS’ EQUITY
Common Stock, 825,000,000 shares authorized, $0.0001 par value, 149,709,078 and 148,439,716 shares issued as of July 4, 2026 and January 3, 2026, respectively
Treasury stock, at cost, 13,243,691 and 9,583,103 shares as of July 4, 2026 and January 3, 2026, respectively
Additional paid in capital
Accumulated other comprehensive loss
Retained earnings
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments